BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-4.41%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.21B
AUM Growth
+$6.21B
(-11%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-3.64%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
166
New
10
Increased
37
Reduced
80
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$31.1M |
| 2 |
UnitedHealth
UNH
|
$24.2M |
| 3 |
Cigna
CI
|
$21.5M |
| 4 |
Humana
HUM
|
$20.8M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$10.5M |
Top Sells
| 1 |
Medtronic
MDT
|
$60.3M |
| 2 |
Inspire Medical Systems
INSP
|
$56.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$32.8M |
| 4 |
Charles River Laboratories
CRL
|
$16.7M |
| 5 |
Thermo Fisher Scientific
TMO
|
$15M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Industrials | 0.77% |
| 3 | Energy | 0.04% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
101
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.67M | 0.08% |
22,000
| – | – |
|
102
Biogen
BIIB
$20.8B
| $4.45M | 0.07% |
17,314
-8,284
| -32% | -$2.13M |
|
103
Esperion Therapeutics
ESPR
$490M
| $4.12M | 0.07% |
4,204,264
-4,000
| -0.1% | -$3.92K |
|
|
NVRO
104
DELISTED
NEVRO CORP.
NVRO
| $3.81M | 0.06% |
198,171
-20,402
| -9% | -$392K |
|
105
Johnson & Johnson
JNJ
$429B
| $3.55M | 0.06% |
22,823
+1,598
| +8% | +$249K |
|
|
OLK
106
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.2M | 0.05% |
217,256
-22,368
| -9% | -$330K |
|
107
Cencora
COR
$57.2B
| $3.08M | 0.05% |
17,087
+1,177
| +7% | +$212K |
|
108
CVS Health
CVS
$93B
| $2.47M | 0.04% |
35,314
| – | – |
|
109
McKesson
MCK
$85.9B
| $2.36M | 0.04% |
5,425
+2,129
| +65% | +$926K |
|
110
Kosmos Energy
KOS
$803M
| $2.32M | 0.04% |
284,000
-34,300
| -11% | -$281K |
|
111
Alkermes
ALKS
$4.95B
| $2.29M | 0.04% |
81,700
| – | – |
|
112
Guardant Health
GH
$8.11B
| $2.21M | 0.04% |
74,525
-7,672
| -9% | -$227K |
|
113
BridgeBio Pharma
BBIO
$9.91B
| $2.08M | 0.03% |
78,700
-18,200
| -19% | -$480K |
|
114
Viatris
VTRS
$12.3B
| $1.74M | 0.03% |
+176,848
| New | +$1.74M |
|
115
Rhythm Pharmaceuticals
RYTM
$6.75B
| $1.68M | 0.03% |
+73,300
| New | +$1.68M |
|
116
Vaxcyte
PCVX
$4.17B
| $1.55M | 0.03% |
30,500
+4,500
| +17% | +$229K |
|
117
Krystal Biotech
KRYS
$4.35B
| $1.45M | 0.02% |
12,500
-5,500
| -31% | -$638K |
|
118
Labcorp
LH
$22.8B
| $1.4M | 0.02% |
6,988
-1,146
| -14% | -$230K |
|
119
Certara
CERT
$1.69B
| $1.33M | 0.02% |
+91,606
| New | +$1.33M |
|
120
Recursion Pharmaceuticals
RXRX
$2.02B
| $1.33M | 0.02% |
+174,085
| New | +$1.33M |
|
121
Akero Therapeutics
AKRO
$3.65B
| $1.26M | 0.02% |
25,000
-2,100
| -8% | -$106K |
|
122
Dynavax Technologies
DVAX
$1.19B
| $1.23M | 0.02% |
+83,200
| New | +$1.23M |
|
|
KRTX
123
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.17M | 0.02% |
6,900
-3,200
| -32% | -$541K |
|
124
Zoetis
ZTS
$67.6B
| $1.12M | 0.02% |
6,462
-34
| -0.5% | -$5.92K |
|
125
SPDR S&P 500 ETF Trust
SPY
$656B
| $1.11M | 0.02% |
2,600
+800
| +44% | +$342K |
|